Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Vanda Pharmaceuticals

Vanda Pharmaceuticals reported $58.24M in Gross Profit on Sales for its fiscal quarter ending in December of 2022.

Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 116.8M 17.28M
Agios Pharmaceuticals AGIO:US USD 5.06M 1.16M
Akebia Therapeutics AKBA:US USD 29.09M 37.35M
Alnylam Pharmaceuticals ALNY:US USD 264.42M 19.35M
AstraZeneca AZN:LN USD 8.83B 130M
Bluebird Bio BLUE:US USD -995000 1.04M
Bristol-Myers Squibb BMY:US USD 8.77B 114M
Eli Lilly LLY:US USD 5.33B 420.4M
Esperion Therapeutics ESPR:US USD 12.68M 1.98M
Halozyme Therapeutics HALO:US USD 126.97M 12.4M
Insmed INSM:US USD 51.38M 5.15M
Intercept Pharmaceuticals ICPT:US USD 67.74M 9.46M
J&J JNJ:US USD 16.35B 356M
Merck & Co MRK:US USD 11.14B 1.15B
Moderna Inc MRNA:US USD 1.07B 2.1B
Novartis NVS:US USD 9.38B 215M
Pfizer PFE:US USD 13.26B 1.21B
PTC Therapeutics PTCT:US USD 206.24M 49.72M
Puma Biotechnology PBYI:US USD 39.56M 9.28M
Takeda 4502:JP JPY 646.38B 114.19B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 1.65B 454M
Ultragenyx Pharmaceutical RARE:US USD 88.24M 9.79M